| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 727985 | NSC 708781 incorporated in micelles, 0.55% (w/w) of drug | 0.0114553853234977 | 0.20340084 |
| NSC 728512 | 1-Allyl-2-[4-chloro-5-(4-chlorophenylcarbamoyl)-2-methylthio benzenesulfonyl]-3-(5-nitro-2-furfulienimino)guanidine | 0.0114553853234977 | 0.12294562 |
| NSC 734278 | Null | 0.0114553853234977 | 0.055679219 |
| NSC 745957 | 2-Benzylthio-4-chloro-N-[imino(3,4,5-trimethylpyrazol-1-yl)methyl]-5-methylbenzenesulfonamide | 0.0114553853234977 | -0.025767352 |
| NSC 747292 | Null | 0.0114553853234977 | 0.062410351 |
| NSC 755417 | Null | 0.0114553853234977 | 0.16162891 |
| NSC 123491 | L-Cysteine, S-[tris(4-methylphenyl)methyl]- (9CI) | 0.0126882509540132 | 0.2353242 |
| NSC 294530 | Null | 0.0126882509540132 | -0.12569131 |
| NSC 5355 | Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy-, sulfate (2:1) (9CI) | 0.0126882509540132 | 0.23357778 |
| NSC 59620 | (4a,6a,9-trimethyl-6,7-dioxo-2,3,4,4b,5,6b,10,10a,11,11a,11b,12,13,13a-tetradecahydro-1H-indeno[2,1-a]phenanthren-2-yl) acetate | 0.0126882509540132 | 0.075036603 |